Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma
Public Domain
-
2006/06/01
-
Details
-
Personal Author:
-
Description:Individualized therapy of lung adenocarcinoma depends on the accurate classification of patients into subgroups of poor and good prognosis, which reflects a different probability of disease recurrence and survival following therapy. However, it is currently impossible to reliably identify specific high-risk patients. Here, we propose a computational model system which accurately predicts the clinical outcome of individual patients based on their gene expression profiles. Gene signatures were selected using feature selection algorithms random forests, correlation-based feature selection, and gain ratio attribute selection. Prediction models were built using random committee and Bayesian belief networks. The prognostic power of the survival predictors was also evaluated using hierarchical cluster analysis and Kaplan-Meier analysis. The predictive accuracy of an identified 37-gene survival signature is 0.96 as measured by the area under the time-dependent receiver operating curves. The cluster analysis, using the 37-gene signature, aggregates the patient samples into three groups with distinct prognoses (Kaplan-Meier analysis, P < 0.0005, log-rank test). All patients in cluster 1 were in stage I, with N0 lymph node status (no metastasis) and smaller tumor size (T1 or T2). Additionally, a 12-gene signature correctly predicts the stage of 94.2% of patients. Our results show that the prediction models based on the expression levels of a small number of marker genes could accurately predict patient outcome for individualized therapy of lung adenocarcinoma. Such an individualized treatment may significantly increase survival due to the optimization of treatment procedures and improve lung cancer survival every year through the 5-year checkpoint. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1078-0432
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:12
-
Issue:11
-
NIOSHTIC Number:nn:20030331
-
Citation:Clin Cancer Res 2006 Jun; 12:3344-3354
-
Contact Point Address:Lan Guo, 1814 HSS, Mary Babb Randolph Cancer Center, P.O. Box 9300, Morgantown, WV 26506-9300
-
Email:lguo@hsc.wvu.edu
-
Federal Fiscal Year:2006
-
NORA Priority Area:
-
Peer Reviewed:True
-
Part Number:1
-
Source Full Name:Clinical Cancer Research
-
Collection(s):
-
Main Document Checksum:urn:sha-512:6cd0244377519bfdf0008ba65120ccccf7e3e4f371075cf75334568df094007721f4ec4e6d9cdde61b548d8f55f20612981314f019ed026d7521c920f83eb6ed
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like